Showing 3661-3670 of 8660 results for "".
Tips for Increasing Practice Efficiency
https://practicaldermatology.com/topics/practice-management/tips-for-increasing-practice-efficiency/21405/How to stay on schedule and keep patients, staff, and physicians happy.Analyzing Risk Factors for Subsequent Primary Melanomas
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-risk-factors-for-subsequent-primary-melanomas/21429/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21460/Goal Alignment, Part II: Developing Related Goals at All Practice Levels
https://practicaldermatology.com/topics/practice-management/goal-alignment-part-ii-developing-related-goals-at-all-practice-levels/21481/Expert Profiles of Fillers for Your Practice
https://practicaldermatology.com/topics/general-topics/expert-profiles-of-fillers-for-your-practice/21486/Experts discuss their experiences with various popular fillers and their benefits for patients.Is It Worth It to Recertify?
https://practicaldermatology.com/topics/practice-management/is-it-worth-it-to-recertify/21492/Psoriasis and the Metabolic Syndrome
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-the-metabolic-syndrome/21535/Growing data support the notion that TNF inhibitors may decrease various risk factors for the metabolic syndrome.EHR User Series: Part I
https://practicaldermatology.com/topics/practice-management/ehr-user-series-part-i/22966/A Q&A series with users of EHR technology about their own experience and their broader impressions of EHR in dermatology.A State of Transition for EHRs
https://practicaldermatology.com/topics/practice-management/a-state-of-transition-for-ehrs/22953/As practitioners await the next step in the larger implementation of this technology, an emphasis on utility is more important than ever.New Products and Pharmacologic Developments
https://practicaldermatology.com/topics/general-topics/new-products-and-pharmacologic-developments/22949/New products and pharmacologic developments